General Shareholders Meetings

In accordance with the Swedish Companies Act, the Annual General Shareholders’ Meeting is Moberg Pharma’s highest decision-making body. At such meetings, the shareholders exercise their voting rights on key issues, such as the adoption of the statements of comprehensive income and financial position, the distribution of unappropriated income, discharging the Members of the Board and the auditors from personal liability and remuneration of Members of the Board and the auditors. In addition to the AGM, Extraordinary General Meetings may be held. In accordance with the Articles of Association, the official notification of the AGM and Extraordinary General Meetings is to be published in Post- och Inrikes Tidningar and on the company’s website. Information that the official notification has been issued will be published in Dagens Industri.

Those shareholders who are directly registered in the share register maintained by Euroclear Sweden AB no later than five days prior to the AGM and who have notified Moberg Pharma in the manner specified in the official notification will be entitled to participate in the AGM and to vote for the number of shares they hold.

Shareholders exercise their right to decide on Moberg Pharma’s affairs at the AGM, which must be held within six months of fiscal year-end; Moberg Pharma's AGM is normally held in the beginning of May. The AGM considers several central issues such as adoption of Moberg Pharma’s income statement and balance sheet for the past year, dividend, board and auditor election, discharging the board from liability, and board and auditor remuneration.

The Annual General Meeting of Moberg Pharma will be held on May 21, 2026. The last date for shareholders to request to have a matter considered at the Annual General Meeting is April 2, 2026.